Antibiotics Presentation

download Antibiotics Presentation

of 42

Transcript of Antibiotics Presentation

  • 8/19/2019 Antibiotics Presentation

    1/42

    Antibiotics

    Cyrus Talwar

  • 8/19/2019 Antibiotics Presentation

    2/42

    Bacteria

    • Gram stain identifes bacteria undermicroscope:

    • Gram +ve (purple/blue)• Gram –ve (red)

  • 8/19/2019 Antibiotics Presentation

    3/42

    Gram !ositive

    " G+ bu#s ($ cocci% &rods)

    ') treptococcus Cocci$) tap ylococcus

    *)Bacillus

    &)Clostridium ods

    ,)Corynebacterium

  • 8/19/2019 Antibiotics Presentation

    4/42

    Gram ne#ative

    ').eisseria

    $) 0Coli*) !roteus

    &)1lebsiella

    ,) !suedomonas

    ") almonella

  • 8/19/2019 Antibiotics Presentation

    5/42

    treptococci (catalyse )

    • trep vs tap 2 CATA-A T T todi3erentiate

    ') Group A strep: ( trep0 !yo#enes) ! aryn#itis-) Cellulitis/ 4in in5ections (necrotisin#

    5asciitis)-) To6ic oc4 yndrome-)

    Also causes delayed antibodymediated 7 and Glomerulone ritis

  • 8/19/2019 Antibiotics Presentation

    6/42

    treptococci

    $) Group B trep:- $,8 o5 women carry t ese bu#s

    va#inally- Cause neonatal menin#itis%

    pneumonia and sepsis

    *) 9ididans Group trep:- ental in5ections-

    ndocarditis

  • 8/19/2019 Antibiotics Presentation

    7/42

    &) Group strep (enterococci and nonenterococci)-

    i;cult to treat due to resistance o5ampicillin and vancomycin

    ,) trep !neumoniae

    Bacterial pneumonia menin#itis in adults

    otitis media in c ildren

  • 8/19/2019 Antibiotics Presentation

    8/42

    tap ylococci (catalase +)

    ') tap Aureus-) !roduces 5 > CT or#an invasion can cause

    pneumonia% ?enin#itis% endocarditis%

    4in in5ections% sepsis% @T>

  • 8/19/2019 Antibiotics Presentation

    9/42

    $) tap pidermis

    Compromised ospital patients witurine cat eters/ >09 lines can becomein5ected w en t is or#anism mi#rates

    5rom t e s4in alon# t e tubin#- eart valve and prost etic in5ections

    *) tap ylococcus saprop yticus

    -eadin# cause o5 @T> in 5emales

  • 8/19/2019 Antibiotics Presentation

    10/42

    To6ins

    6oto6ins !roteins release by G+ andG 0 >ncludes .euroto6ins% nteroto6ins(causes diarr oea by .aCl release)0

    Causes >.7 CT>=@ >A = A and7== !=> =.>.G

    ndoto6ins lipid A w ic is outermembrane piece o5 G bacteria0 9eryto6ic so antibiotics can ma4e patientsworse initially due to release o5endoto6in

  • 8/19/2019 Antibiotics Presentation

    11/42

    Gram bacteria

    • .eisseria ?enin#itidis causesmenin#ococcal menin#itis 0Causespetic eal ras

    • -e#ionella !neumonia ( atypical

    pneumoniaD) Eell aerated water (airconditionin# units% water stora#e)

  • 8/19/2019 Antibiotics Presentation

    12/42

    E at are antibiotics2

    - Compounds t at act a#ainst bacteria(FAntimicrobials viruses% parasites%5un#i)

    4ill (bacteriacidal) or in ibit(bacteriostatic)

    administered as oral% parenteral ortopical

    resistance may rapidly develop

  • 8/19/2019 Antibiotics Presentation

    13/42

    Antibiotics t at inter5ere

    wit cell wall') !enicillins$) Cep alosporins B lactams

    *) Carbapenams

    &) Glycopeptides

  • 8/19/2019 Antibiotics Presentation

    14/42

    ') !enicillinHs

    • !enicillin G (benpen) #iven >0?/>09( trep0 !neumoniae)

    Aminopenicillins(Ampicillin/Amo6icillin) Broaderspectrum% more G cover0 >ncreasin#resistance

    • !enicillinase resistant(?et icillin/7luclo6acillin) – used 5orG+% #ood a#ainst stap aureus

  • 8/19/2019 Antibiotics Presentation

    15/42

    B lacamase in ibitors

    • Given in combination wit penicillinHs• >n ibitors o5 b lacamase

    Amo6icillin + Clavulanic acidICoamo6iclav

    !ipericillin + TaJobactam I TaJocin

  • 8/19/2019 Antibiotics Presentation

    16/42

    $) Cep alosoporins

    • ?ore resistant to b lactamaseenJymes t an penecillin

    'st Gen: G+ covera#e• $nd Gen: use5ul in CA!• *rd Gen: G covera#e0 @se5ul in

    nosocomial in5ections% menin#itis and@T>s0 as best C 7 penetration0

    • ome cross reactivity in patients witpenicillin aller#y

  • 8/19/2019 Antibiotics Presentation

    17/42

    *) Carbapenams

    • Broadest spectrum b lacatams• as anaerobic cover

    • -owers seiJure t res old

  • 8/19/2019 Antibiotics Presentation

    18/42

    &) Glycopeptides

    • Glycopeptides bacteriocidal: inter5erewit cell wall – #ram +ves only

    9ancomycin/teicoplanin• ? A treatment•

    .ep roto6ic (don t #ive wit #entamicin)

    • .eed to monitor levels – B re#ime L

  • 8/19/2019 Antibiotics Presentation

    19/42

    • .arrow spectrum: BenJyl pen andpen 9 5or streptococci% neisseria%clostridia

    • Amo6 and ampicillin e6tend spectrumto enterococci% listeria% emop ilus

    Amo6 clavulanic acid e6tendsspectrum to stap ylococci% coli5orms%anaerobes

    7luclo6acillin 5or ? A

  • 8/19/2019 Antibiotics Presentation

    20/42

    Antibiotics t at in ibit

    protein synt esis') ?acrolides$) Amino#lycosides

    *) Tetracyclins&) =t ers

    (c loramp enicol/clindamycin/5usidic acid)

  • 8/19/2019 Antibiotics Presentation

    21/42

    ') ?acrolides

    • ryt romycin% clarit romycin• Alternative to penicillin

    • Clindamycin can causepseudomembranous colitis as itdestroys natural #ut Mora

    • ?ainly act a#ainst G+

  • 8/19/2019 Antibiotics Presentation

    22/42

    $) Amino#lycosides

    • Gentamycin% streptomycin• ?ust enter cell wall to wor4 so o5ten

    used wit penicillinHs• 1ill G or#anisms• .arrow t erapeutic window• .ep roto6ic and ototo6ic

  • 8/19/2019 Antibiotics Presentation

    23/42

    *) Tetracyclins

    • o6ycycline• use5ul activity a#ainst c lamydiae%

    mycoplasmas% ric4ettsias andCo6iella burnetii as well asstap ylococci% streptococci and someGram ne#ative rods

    • T ey must not be used in pre#nancy%in c ildren or in renal impairment0

  • 8/19/2019 Antibiotics Presentation

    24/42

    Antibiotics t at in ibit .A

    syt esis• Nuinolones (CiproMo6acin)• >n ibit .A #yrase

    • CiproMo6acin is a #ram ne#ativeantibiotic wit no activity a#ainstpneumococcus

  • 8/19/2019 Antibiotics Presentation

    25/42

    ?etronidaJole

    • >n ibits .A synt esis• Causes metallic taste and intolerance

    to alc ol• Good 5or anaerobes• !er5oration o5 bowel /bowel sur#ery L

    metronidaJole and coOamo6iclav• 'st line C0di3 treatment

  • 8/19/2019 Antibiotics Presentation

    26/42

    ulp onamides

    • 0# trimet roprim• >n ibit 5olate synt esis

    • @se5ul in @T>• ulp onamides can ave nasty side

    e3ects e0#0 tevens Po nson

    syndrome Q bone marrow aplasia0

  • 8/19/2019 Antibiotics Presentation

    27/42

  • 8/19/2019 Antibiotics Presentation

    28/42

  • 8/19/2019 Antibiotics Presentation

    29/42

    Condition Drug

    UTI-Uncomplicated 'st: .itro5urantoin –$nd: Trimet oprim –*rd: Ce5ale6in –? A –nitro5urantoin andtrimet oprim and do6ycycline

    Acute Prostatitis 'st: CiproMo6acin

    $nd: Trimet oprim*rd: Tetracycline

    Pyelonephritis (andcomplicated UTI’s)

    'st: CiproMo6acin / ce5uro6ime$nd: Co amo6iclav>9 – #entamycin

    Genital bacterial in ections(General)

    ?etronidaJole

    PID ?etronidaJole o6ycycline

    Chlamydia o6ycycline

    Gonorrhoea CiproMo6acin% Amo6icilin% !robenicid

    !aginal ungal in ections ClotrimaJole pessary

    Antibiotics 5or urolo#yconditions

  • 8/19/2019 Antibiotics Presentation

    30/42

    Antibiotics 5or respiratory

    conditionsCondition Drug"o#er respiratory tractin ection ("$TI)

    Amo6icillinryt romycin

    C%PD acute e&acerbation Amo6icillin R Clarit ro i5 pen aller#y

    Co amo6iclavCiproMo6acin

    'ronchiectasis Amo6icillino6ycyclin

    Pneumonia S – Amo6icillin (clarit ro)

    ' – Amo6icillin + clarit ro0$ >9 Amo60 + clarit ro0* , – >9 au#mentin + clarit

  • 8/19/2019 Antibiotics Presentation

    31/42

    Antibiotics 5or .T

    conditionsCondition Drug%titis edia Amo6icillin

    ryt romycinCo amo6iclav

    Dental in ections Penicillin ! A*D Chlorohe&idine mouth#ash+rythromycin

    etronida,ole

    Pharyngitis !enicillin 9ryt romycin

    %ral candidiasis .ystatin (can be pastille orsuspension) 7luconaJole (tablet)

  • 8/19/2019 Antibiotics Presentation

    32/42

    Antibiotics 5or G> conditions

    Condition Drug

    Peritonitis Amo6icillin – A. –Gentamycin – A. –?etronidaJole9ancomycin (instead o5 amo6icillin

    epsis TaJocinGentamicin

  • 8/19/2019 Antibiotics Presentation

    33/42

    Be5ore prescribin# A6 0

    -oo4 5or si#ns o5 in5ection:

    • Pain• .e/er•

    #elling• $edness• tachycardia• ri ors

  • 8/19/2019 Antibiotics Presentation

    34/42

    • Antibiotics s ould only be #ivenw en t ere is proven or stron#lysuspected bacterial in5ection

    • (or w en t ere is a possibility o5bacterial in5ection and t e patient isso sic4 you cannot a3ord not to treatt at small possibility)

  • 8/19/2019 Antibiotics Presentation

    35/42

    @r#ent re uirements 5orantibiotics

    • ?enin#ococcal disease• =t er bacterial menin#itis

    • epsis• evere pneumonia• .ecrotisin# 5asciitis• = B-== C@-T@ U

  • 8/19/2019 Antibiotics Presentation

    36/42

    ystemic inMammatory

    response syndrome• Temperature V*W or X*"• !ulse VYS

    • espiratory rate V$S or pC=$ X &0*

    • ECC V '$SSS or X &SSS

  • 8/19/2019 Antibiotics Presentation

    37/42

    efnitions

    • epsis I > due to in5ection• evere sepsis I sepsis + or#an

    dys5unction• eptic s oc4 I sepsis + re5ractory

    ypotension

  • 8/19/2019 Antibiotics Presentation

    38/42

    epsis

    Clinically:• 7ever

    • Tac ycardia• .i# t sweats• To6ic% Mus ed ( vasodilated )• i# w ite cell count• -ocalisin# symptoms and si#ns

    Complications

  • 8/19/2019 Antibiotics Presentation

    39/42

    ?enin#itis

    ?ost causes are community ac uired• Neisseria meningitidis

    • Streptococcus pneumoniae • Haemophilus infuenzae• Listeria monocytogenes • >n neonates: Group B streptococci

    and Gram ne#ative bacilli as well as

    listeria

  • 8/19/2019 Antibiotics Presentation

    40/42

    ?enin#itis

    • tart A6 immediately(Ce5ota6ine/Ce5tria6one)

    Acyclovir i5 viral• >5 not yet in ospital #ive '0$G >?

    BenJylpenecillin

  • 8/19/2019 Antibiotics Presentation

    41/42

    C 7 fndin#WCC

    /mm3roteing/L

    !lucosemmol/L

    Normal Z,lymp ocytes

    S0', S0&, $0W &0$V'/$ blood #lucose

    "acterial $SS *SSS(neutrop ils)

    S0, $0S X'/* blood #lucose(X$0,)

    #iral 'S 'SS(lymp ocytes)

    S0& S0W V'/$ blood #lucose

    $" ,S ,SS(lymp ocytes)

    S0, *0S X'/* blood #lucose

  • 8/19/2019 Antibiotics Presentation

    42/42

    emember

    • Classes o5 antibiotics• ow t ey wor4

    • E ic or#anisms t ey cover• >mportant in5ections and 6• on t 5or#et Blood culturesU